These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 28858374)

  • 1. PTEN allelic loss is an important mechanism in the late stage of development of oral leucoplakia into oral squamous cell carcinoma.
    Miyahara LAN; Pontes FSC; Burbano RMR; Conte Neto N; Guimarães DM; Fonseca FP; Pontes HAR
    Histopathology; 2018 Jan; 72(2):330-338. PubMed ID: 28858374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of heterozygosity and immunoexpression of PTEN in oral epithelial dysplasia and squamous cell carcinoma.
    Chaves FN; Bezerra TMM; Moraes DC; Costa SFDS; Silva PGB; Alves APNN; Costa FWG; Bernardes VF; Pereira KMA
    Exp Mol Pathol; 2020 Feb; 112():104341. PubMed ID: 31730755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MCM3 could be a better marker than Ki-67 for evaluation of dysplastic oral lesions: an immunohistochemical study.
    Lameira AG; Pontes FS; Guimarães DM; Alves AC; de Jesus AS; Pontes HA; Pinto Ddos S
    J Oral Pathol Med; 2014 Jul; 43(6):427-34. PubMed ID: 24456424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTEN gene polymorphisms and susceptibility to oral squamous cell carcinoma in a Chinese Han population.
    Yang XD; Zhao SF; Zhang Q; Li W; Wang YX; Hong XW; Hu QG
    Tumour Biol; 2016 Jan; 37(1):577-82. PubMed ID: 26232326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gain of hTERC: a genetic marker of malignancy in oral potentially malignant lesions.
    Dorji T; Monti V; Fellegara G; Gabba S; Grazioli V; Repetti E; Marcialis C; Peluso S; Di Ruzza D; Neri F; Foschini MP
    Hum Pathol; 2015 Sep; 46(9):1275-81. PubMed ID: 26170010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating microRNA-21 (MIR-21) and phosphatase and tensin homolog (PTEN) are promising novel biomarkers for detection of oral squamous cell carcinoma.
    Ren W; Qiang C; Gao L; Li SM; Zhang LM; Wang XL; Dong JW; Chen C; Liu CY; Zhi KQ
    Biomarkers; 2014 Nov; 19(7):590-6. PubMed ID: 25174622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
    Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
    Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTEN and p16 genes as epigenetic biomarkers in oral squamous cell carcinoma (OSCC): a study on south Indian population.
    Sushma PS; Jamil K; Kumar PU; Satyanarayana U; Ramakrishna M; Triveni B
    Tumour Biol; 2016 Jun; 37(6):7625-32. PubMed ID: 26687648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can molecular assessment improve classification of head and neck premalignancy?
    Mao L
    Clin Cancer Res; 2000 Feb; 6(2):321-2. PubMed ID: 10690505
    [No Abstract]   [Full Text] [Related]  

  • 10. [Detection of TP53-mutations in brush biopsies from oral leukoplakias].
    Scheifele C; Schlechte H; Bethke G; Reichart PA
    Mund Kiefer Gesichtschir; 2002 Nov; 6(6):410-4. PubMed ID: 12447653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTEN and miR-26b: Promising prognostic biomarkers in initiation and progression of Oral Squamous Cell Carcinoma.
    Baghaei F; Abdollahi A; Mohammadpour H; Jahanbin M; Naseri Taheri F; Aminishakib P; Emami Razavi A; Kharazifard M
    J Oral Pathol Med; 2019 Jan; 48(1):31-35. PubMed ID: 30372795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic profile of PTEN gene in Indian oral squamous cell carcinoma primary tumors.
    Shah S; Jajal D; Mishra G; Kalia K
    J Oral Pathol Med; 2017 Feb; 46(2):106-111. PubMed ID: 27381359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of the clock gene PER2 is associated with cancer development and altered expression of important tumor-related genes in oral cancer.
    Xiong H; Yang Y; Yang K; Zhao D; Tang H; Ran X
    Int J Oncol; 2018 Jan; 52(1):279-287. PubMed ID: 29115399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDC28 protein kinase regulatory subunit 1B (CKS1B) expression and genetic status analysis in oral squamous cell carcinoma.
    Martín-Ezquerra G; Salgado R; Toll A; Baró T; Mojal S; Yébenes M; Garcia-Muret MP; Solé F; Quitllet FA; Espinet B; Pujol RM
    Histol Histopathol; 2011 Jan; 26(1):71-7. PubMed ID: 21117028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semiquantifiable angiogenesis parameters in association with the malignant transformation of oral leukoplakia.
    Thiem DGE; Schneider S; Venkatraman NT; Kumar VV; Brieger J; Frerich B; Kämmerer PW
    J Oral Pathol Med; 2017 Oct; 46(9):710-716. PubMed ID: 28036153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Copy Number Alterations Predict Development of OSCC from Oral Leukoplakia.
    Cai X; Zhang J; Li L; Liu L; Tang M; Zhou X; Peng C; Li X; Chen X; Xu M; Zhang H; Wang J; Huang Y; Li T
    J Dent Res; 2024 Feb; 103(2):138-146. PubMed ID: 38217281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of immunomodulatory mediators in oral precancerous lesions.
    Gonçalves AS; Mosconi C; Jaeger F; Wastowski IJ; Aguiar MCF; Silva TA; Ribeiro-Rotta RF; Costa NL; Batista AC
    Hum Immunol; 2017 Nov; 78(11-12):752-757. PubMed ID: 28941745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of TP53 in the progression of pre-malignant and malignant oral mucosal lesions. A follow-up study of 144 patients.
    Ogmundsdóttir HM; Björnsson J; Holbrook WP
    J Oral Pathol Med; 2009 Aug; 38(7):565-71. PubMed ID: 19473450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-21 promotes perineural invasion and impacts survival in patients with oral carcinoma.
    Yu EH; Tu HF; Wu CH; Yang CC; Chang KW
    J Chin Med Assoc; 2017 Jun; 80(6):383-388. PubMed ID: 28254348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress risk assessment of oral premalignant lesions with saliva miRNA analysis.
    Yang Y; Li YX; Yang X; Jiang L; Zhou ZJ; Zhu YQ
    BMC Cancer; 2013 Mar; 13():129. PubMed ID: 23510112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.